| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | — | — |
| R&D Expense | $7K | — | -12.5% |
| SG&A Expense | $245K | — | +12.4% |
| Operating Income | -$249K | — | -10.2% |
| Interest Expense | $9K | — | +800.0% |
| Net Income | -$258K | — | -13.7% |
| EPS (Basic) | $0.00 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30K | -88.0% | +1400.0% |
| Accounts Receivable | $5K | -50.0% | — |
| Current Assets | $49K | -82.9% | +16.7% |
| Total Assets | $60K | -79.8% | -22.1% |
| Current Liabilities | $99K | -2.9% | -84.9% |
| Long-term Debt | $150K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$219K | — | -25.1% |
| Financing Cash Flow | $0 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | — |
| +11.1% |
| +17.2% |
| Total Liabilities | $249K | +9.2% | -68.2% |
| Stockholders' Equity | -$189K | -373.9% | +73.3% |